PROCEPT BioRobotics (PRCT) Free Cash Flow (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Free Cash Flow for 7 consecutive years, with -$22.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Free Cash Flow fell 24.43% year-over-year to -$22.2 million in Q2 2026; TTM through Jun 2026 was -$84.9 million, a 4.87% increase from a year earlier, with the FY2025 full-year figure at -$58.3 million, up 43.7% from the prior year.
• Free Cash Flow was -$22.2 million for Q2 2026 at PROCEPT BioRobotics, up from -$41.0 million in the prior quarter.
• Over five years, Free Cash Flow peaked at -$9.5 million in Q3 2025 and troughed at -$41.3 million in Q1 2023.
• A 5-year average of -$24.6 million and a median of -$21.6 million in 2022 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow plunged 122.08% in 2023 and soared 63.72% in 2025, its largest moves.
• Over 5 years, Free Cash Flow stood at -$26.9 million in 2022, then dropped by 24.42% to -$33.5 million in 2023, then fell by 0.17% to -$33.6 million in 2024, then soared by 63.72% to -$12.2 million in 2025, then sank by 82.34% to -$22.2 million in 2026.
• The last three Free Cash Flow figures came in at -$22.2 million (Q2 2026), -$41.0 million (Q1 2026), and -$12.2 million (Q4 2025), per Business Quant data.